Previous 10 | Next 10 |
Concrete segment secures awards totaling $100 million in core markets of Dallas and Houston Largest diving services contract in Company history HOUSTON, March 10, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company"), a leading specialty construction ...
Orion Group ( NYSE: ORN ) on Thursday said Austin Shanfelter will transition back to chairman of the board. Shanfelter had been serving as executive chairman since relinquishing his roles as interim CEO and CFO in Sept. 2022. According to the company, Shanfelter has served on ...
HOUSTON, March 02, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) ("Company"), a leading specialty construction company, today announced that Austin J. Shanfelter will transition from Executive Chairman to Chairman of the Board of Directors, effective March 2, 2023. Mr. Shanf...
HOUSTON, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company"), a leading specialty construction company, today announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2022 on Tuesday, March 14, 2023, after the ...
MADRID, Spain and BOSTON, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it will host a virtual panel di...
Strong clinical progress in both oncology and CNS Cash, cash equivalents and marketable securities totaled $22.7 million as of December 31, 2022 MADRID, Spain and BOSTON, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biophar...
(NewsDirect) Orion Minerals Ltd (ASX:ORN, JSE:ORN) CEO Errol Smart speaks with Proactive soon after announcing the company has signed a definitive agreement for a ZAR 250 million (~A$21 million) senior secured convertible loan facility with the Industrial Development Corporation of South Afri...
BIO CEO & Investor Conference 2023 IASLC 2023 Targeted Therapies of Lung Cancer Meeting 16th Annual European Life Sciences CEO Forum Cancer Epigenetics Institute Symposium: From Genes to Chromatin to Therapeutics BioCapital Europe 2023 BIO-EUROPE Sp...
Summary January 2023 was an amazing month to be long equities. The Russell 2000 index was up 9.8%. Before the first opening bell of 2023, I created an equal weighted and bespoke list of twenty nine stocks for my January Effect 2023 model portfolio. The January Effect 2023 portfolio ...
Collaborative study with Fox Chase Cancer Center Trial will assess the safety and efficacy of iadademstat in pulmonary and extrapulmonary NECs Part of a broad collaboration with The Cancer Epigenetics Institute (CEI) MADRID, Spain and BOSTON, Jan. 18, 2023 (GLOBE NEWSWIR...
News, Short Squeeze, Breakout and More Instantly...
Orion Group Holdings Inc. Common Company Name:
ORN Stock Symbol:
NYSE Market:
Orion Group Holdings Inc. Common Website:
MADRID and CAMBRIDGE, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it has received “Deci...
HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (“Orion”, "Company"), a leading specialty construction company, today announced that it will issue its second quarter 2024 financial results after the close of the stock market on Wednesday, July 24, 2...
2024-07-06 15:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...